Clinical care, daily operations and professional learning. Choose the tools that fit your pharmacy.
Clinical care, daily operations and professional learning. Choose the tools that fit your pharmacy.
A private member’s bill would authorize pharmacists to prescribe designated drugs for a wider list of minor conditions, but regulations, safeguards and a delayed start date would still be required.
Read the briefing
The pan-Canadian Pharmaceutical Alliance lists ELAHERE negotiations as concluded with a letter of intent, after AbbVie announced the agreement on October 21. The milestone moves the drug closer to possible public reimbursement, but provincial and territorial plan listings still follow.
Read the briefing
Health Canada has expanded risankizumab’s Canadian indication to children aged 6 to under 18 with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. The approval changes the product label; coverage decisions remain separate.
Read the briefing